Pneumonitis	pneumonitis	O	O
with	with	O	O
pleural	pleural	O	O
and	and	O	O
pericardial	pericardial	O	B_disease
effusion	effusion	O	I_disease
and	and	O	O
neuropathy	neuropathy	O	S_disease
during	during	O	O
amiodarone	amiodarone	S_chemical	O
therapy	therapy	O	O
.	.	O	O

A	a	O	O
patient	patient	O	O
with	with	O	O
sinuatrial	sinuatrial	O	O
disease	disease	O	O
and	and	O	O
implanted	implanted	O	O
pacemaker	pacemaker	O	O
was	was	O	O
treated	treated	O	O
with	with	O	O
amiodarone	amiodarone	S_chemical	O
(	(	O	O
maximum	maximum	O	O
dose	dose	O	O
1000	1000	O	O
mg	mg	O	O
,	,	O	O
maintenance	maintenance	O	O
dose	dose	O	O
800	800	O	O
mg	mg	O	O
daily	daily	O	O
)	)	O	O
for	for	O	O
10	10	O	O
months	months	O	O
,	,	O	O
for	for	O	O
control	control	O	O
of	of	O	O
supraventricular	supraventricular	O	O
tachyarrhythmias	tachyarrhythmias	O	O
.	.	O	O

He	he	O	O
developed	developed	O	O
pneumonitis	pneumonitis	O	O
,	,	O	O
pleural	pleural	O	O
and	and	O	O
pericardial	pericardial	O	B_disease
effusions	effusions	O	I_disease
,	,	O	O
and	and	O	O
a	a	O	O
predominantly	predominantly	O	O
proximal	proximal	O	O
motor	motor	O	O
neuropathy	neuropathy	O	S_disease
.	.	O	O

Immediate	immediate	O	O
but	but	O	O
gradual	gradual	O	O
improvement	improvement	O	O
followed	followed	O	O
withdrawal	withdrawal	O	O
of	of	O	O
amiodarone	amiodarone	S_chemical	O
and	and	O	O
treatment	treatment	O	O
with	with	O	O
prednisolone	prednisolone	S_chemical	O
.	.	O	O

Review	review	O	O
of	of	O	O
this	this	O	O
and	and	O	O
previously	previously	O	O
reported	reported	O	O
cases	cases	O	O
indicates	indicates	O	O
the	the	O	O
need	need	O	O
for	for	O	O
early	early	O	O
diagnosis	diagnosis	O	O
of	of	O	O
amiodarone	amiodarone	S_chemical	O
pneumonitis	pneumonitis	O	O
,	,	O	O
immediate	immediate	O	O
withdrawal	withdrawal	O	O
of	of	O	O
amiodarone	amiodarone	S_chemical	O
,	,	O	O
and	and	O	O
prompt	prompt	O	O
but	but	O	O
continued	continued	O	O
steroid	steroid	S_chemical	O
therapy	therapy	O	O
to	to	O	O
ensure	ensure	O	O
full	full	O	O
recovery	recovery	O	O
.	.	O	O

